This course will present and detail the variety of current regulatory forces that need to be considered in clinical practice; how they can potentially impact clinical decisions regarding chronic pain; and how they can be negotiated.
MONTCLAIR, N.J. (PRWEB)
October 03, 2019
PAINWeekEnd on October 26 at the DoubleTree by Hilton Hotel Philadelphia Center City, 237 S Broad Street in Pennsylvania, will be an educational and exciting program providing busy clinicians and allied healthcare practitioners with 6.0 hours of relevant, practical instruction in the management of chronic pain.
Heroin and opioid overdose are the leading cause of accidental death in Pennsylvania, with at least 10 people dying each day. Governor Tom Wolf and other politicians have made a commitment to fight this epidemic. Pennsylvania’s 55 Centers of Excellence serve as treatment hubs to treat people with opioid-related substance use disorders though the medical system. The curriculum to be presented at PAINWeekEnd Philadelphia will equip participants with knowledge and skills to better negotiate the changing regulatory landscape for prescribers while meeting the needs of their patients with pain. Senior PAINWeek faculty member Kevin Zacharoff, MD, FACPE, FACIP, FAAP, will lead an examination of the role of illicit substances in the overdose epidemic in his course The Other Opioid Crisis: Heroin and Fentanyl. Dr. Zacharoff has also lectured widely on the impact of expanding regulatory oversight on the practice of pain management, particularly with respect to the interests of the most important stakeholder: the patient. At PAINWeekEnd, Dr. Zacharoff will present The Regulatory Agency Will See You Now about which he commented, “This course will present and detail the variety of current regulatory forces that need to be considered in clinical practice; how they can potentially impact clinical decisions regarding chronic pain; and how they can be negotiated.”
Other course topics to be offered at PAINWeekEnd Philadelphia include Bridges to Babylon: Assessing & Managing Comorbidities in Chronic Pain Patients; 3’s Company: COX-2 Inhibitors, Medicinal Marijuana, and Opioid Prescribing; Do As I Say! Facilitating Treatment Adherence in Pain Medicine; To Dream the Impossible Dream: Acute Pain Management for Patients on Buprenorphine.
Commercially supported activities—addressing a range of product, disease state, and medical information topics—will also be presented.
For more information about this or other regional conferences, and to register for $129, go to the PAINWeekEnd website. BONUS: PAINWeekEnd registrants may register for the 2020 PAINWeek National Conference, September 8-12, in Las Vegas, for $200 off the regular online published price.
PAINWeekEnd is provided by Global Education Group. About Global Education Group:
Global Education Group focuses on producing partnership-based CME for healthcare practitioners. The Global team works with a select group of medical education companies, associations, academic institutions and healthcare facilities to develop and accredit live healthcare conferences and workshops as well as online activities. With each partnership or joint providership, Global brings accreditation expertise, project management excellence and grant funding intelligence. Based in Littleton, Colo., Global has accreditation with commendation from the ACCME. Global also holds accreditations to offer continuing education for nurses, nurse practitioners, pharmacists, dietitians, dentists and psychologists. Global is a division of Ultimate Medical Academy.
Share article on social media or email: